Hicham Skali1, Amil Shah2, Deepak K Gupta2, Susan Cheng2, Brian Claggett2, Jiankang Liu2, Natalie Bello2, David Aguilar2, Orly Vardeny2, Kunihiro Matsushita2, Elizabeth Selvin2, Scott Solomon2. 1. From the Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.S., A.S., S.C., B.C., J.L., S.S.); Vanderbilt University School of Medicine, Nashville, TN (D.K.G.); Columbia University Medical Center, New York, NY (N.B.); Baylor College of Medicine, Houston, TX (D.A.); University of Wisconsin School of Pharmacy, Madison (O.V.); and Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M., E.S.). hskali@post.harvard.edu. 2. From the Brigham and Women's Hospital, Harvard Medical School, Boston, MA (H.S., A.S., S.C., B.C., J.L., S.S.); Vanderbilt University School of Medicine, Nashville, TN (D.K.G.); Columbia University Medical Center, New York, NY (N.B.); Baylor College of Medicine, Houston, TX (D.A.); University of Wisconsin School of Pharmacy, Madison (O.V.); and Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M., E.S.).
Abstract
BACKGROUND: Individuals with diabetes mellitus and pre-diabetes mellitus are at particularly high risk of incident heart failure or death, even after accounting for known confounders. Nevertheless, the extent of impairments in cardiac structure and function in elderly individuals with diabetes mellitus and pre-diabetes mellitus is not well known. We aimed to assess the relationship between echocardiographic measures of cardiac structure and function and dysglycemia. METHODS AND RESULTS: We assessed measures of cardiac structure and function in 4419 participants without prevalent coronary heart disease or heart failure who attended the Atherosclerosis Risk In the Community (ARIC) visit 5 examination (2011-2013) and underwent transthoracic echocardiography (age, 75±6 years; 61% women, 23% black). Subjects were grouped across the dysglycemia spectrum as normal (39%), pre-diabetes mellitus (31%), or diabetes mellitus (30%) based on medical history, antidiabetic medication use, and glycated hemoglobin levels. Glycemic status was related to measures of cardiac structure and function. Worsening dysglycemia was associated with increased left ventricular mass, worse diastolic function, and subtle reduction in left ventricular systolic function (P≤0.01 for all). For every 1% higher glycated hemoglobin, left ventricular mass was higher by 3.0 g (95% confidence interval, 1.5-4.6 g), E/E' by 0.5 (95% confidence interval, 0.4-0.7), and global longitudinal strain by 0.3% (95% confidence interval, 0.2-0.4) in multivariable analyses. CONCLUSIONS: In a large contemporary biracial cohort of elderly subjects without prevalent cardiovascular disease or heart failure, dysglycemia was associated with subtle and subclinical alterations of cardiac structure, and left ventricular systolic and diastolic function. It remains unclear whether these are sufficient to explain the heightened risk of heart failure in individuals with diabetes mellitus.
BACKGROUND: Individuals with diabetes mellitus and pre-diabetes mellitus are at particularly high risk of incident heart failure or death, even after accounting for known confounders. Nevertheless, the extent of impairments in cardiac structure and function in elderly individuals with diabetes mellitus and pre-diabetes mellitus is not well known. We aimed to assess the relationship between echocardiographic measures of cardiac structure and function and dysglycemia. METHODS AND RESULTS: We assessed measures of cardiac structure and function in 4419 participants without prevalent coronary heart disease or heart failure who attended the Atherosclerosis Risk In the Community (ARIC) visit 5 examination (2011-2013) and underwent transthoracic echocardiography (age, 75±6 years; 61% women, 23% black). Subjects were grouped across the dysglycemia spectrum as normal (39%), pre-diabetes mellitus (31%), or diabetes mellitus (30%) based on medical history, antidiabetic medication use, and glycated hemoglobin levels. Glycemic status was related to measures of cardiac structure and function. Worsening dysglycemia was associated with increased left ventricular mass, worse diastolic function, and subtle reduction in left ventricular systolic function (P≤0.01 for all). For every 1% higher glycated hemoglobin, left ventricular mass was higher by 3.0 g (95% confidence interval, 1.5-4.6 g), E/E' by 0.5 (95% confidence interval, 0.4-0.7), and global longitudinal strain by 0.3% (95% confidence interval, 0.2-0.4) in multivariable analyses. CONCLUSIONS: In a large contemporary biracial cohort of elderly subjects without prevalent cardiovascular disease or heart failure, dysglycemia was associated with subtle and subclinical alterations of cardiac structure, and left ventricular systolic and diastolic function. It remains unclear whether these are sufficient to explain the heightened risk of heart failure in individuals with diabetes mellitus.
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista Journal: J Am Soc Echocardiogr Date: 2009-02 Impact factor: 5.251
Authors: J E Liu; V Palmieri; M J Roman; J N Bella; R Fabsitz; B V Howard; T K Welty; E T Lee; R B Devereux Journal: J Am Coll Cardiol Date: 2001-06-01 Impact factor: 24.094
Authors: Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell Journal: Circ Cardiovasc Imaging Date: 2010-03-05 Impact factor: 7.792
Authors: Laura Ernande; Ernst R Rietzschel; Cyrille Bergerot; Marc L De Buyzere; Frédéric Schnell; Laure Groisne; Michel Ovize; Pierre Croisille; Philippe Moulin; Thierry C Gillebert; Geneviève Derumeaux Journal: J Am Soc Echocardiogr Date: 2010-10-08 Impact factor: 5.251
Authors: Scott D Solomon; Martin St John Sutton; Gervasio A Lamas; Ted Plappert; Jean L Rouleau; Hicham Skali; Lemuel Moyé; Eugene Braunwald; Marc A Pfeffer Journal: Circulation Date: 2002-09-03 Impact factor: 29.690
Authors: Arnold C T Ng; Victoria Delgado; Matteo Bertini; Rutger W van der Meer; Luuk J Rijzewijk; Miriam Shanks; Gaetano Nucifora; Johannes W A Smit; Michaela Diamant; Johannes A Romijn; Albert de Roos; Dominic Y Leung; Hildo J Lamb; Jeroen J Bax Journal: Am J Cardiol Date: 2009-09-26 Impact factor: 2.778
Authors: Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray Journal: Eur Heart J Date: 2008-04-14 Impact factor: 29.983
Authors: Jelena P Seferovic; Brian Claggett; Sara B Seidelmann; Ellen W Seely; Milton Packer; Michael R Zile; Jean L Rouleau; Karl Swedberg; Martin Lefkowitz; Victor C Shi; Akshay S Desai; John J V McMurray; Scott D Solomon Journal: Lancet Diabetes Endocrinol Date: 2017-03-18 Impact factor: 32.069
Authors: Jennifer E Ho; Elizabeth L McCabe; Thomas J Wang; Martin G Larson; Daniel Levy; Connie Tsao; Jayashri Aragam; Gary F Mitchell; Emelia J Benjamin; Ramachandran S Vasan; Susan Cheng Journal: Circ Heart Fail Date: 2017-05 Impact factor: 8.790
Authors: Ryan T Demmer; Matthew A Allison; Jianwen Cai; Robert C Kaplan; Ankit A Desai; Barry E Hurwitz; Jill C Newman; Sanjiv J Shah; Katrina Swett; Gregory A Talavera; Ashley Thai; Marston E Youngblood; Carlos J Rodriguez Journal: Circ Cardiovasc Imaging Date: 2016-10 Impact factor: 7.792
Authors: Aseel Alfuhied; Gaurav S Gulsin; Lavanya Athithan; Emer M Brady; Kelly Parke; Joseph Henson; Emma Redman; Anna-Marie Marsh; Thomas Yates; Melanie J Davies; Gerry P McCann; Anvesha Singh Journal: Int J Cardiovasc Imaging Date: 2022-03-02 Impact factor: 2.357
Authors: Xuejuan Ning; Ning Ding; Shoshana H Ballew; Caitlin W Hicks; Josef Coresh; Elizabeth Selvin; James Pankow; Weihong Tang; Kunihiro Matsushita Journal: Atherosclerosis Date: 2020-10-06 Impact factor: 5.162
Authors: João Sérgio Neves; Simon Correa; Rute Baeta Baptista; Miguel Bigotte Vieira; Sushrut S Waikar; Finnian R Mc Causland Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: Michael C Honigberg; Seyedeh M Zekavat; James P Pirruccello; Pradeep Natarajan; Muthiah Vaduganathan Journal: J Am Coll Cardiol Date: 2021-05-17 Impact factor: 27.203
Authors: Sven-Oliver Tröbs; Jürgen H Prochaska; Sören Schwuchow-Thonke; Andreas Schulz; Felix Müller; Marc William Heidorn; Sebastian Göbel; Simon Diestelmeier; Jaume Lerma Monteverde; Karl J Lackner; Tommaso Gori; Thomas Münzel; Philipp S Wild Journal: JAMA Cardiol Date: 2021-04-01 Impact factor: 30.154